Covid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Covid) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Blood pressure high (regularly takes blood pressure medication, and after taking her liquid high blood pressure medication her cough improved).   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In November 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jun-2022, the patient experienced COVID-19 (Covid). In June 2022, COVID-19 (Covid) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2022, SARS-CoV-2 test: (Negative) Negative. On 18-Jun-2022, SARS-CoV-2 test: (Positive) Positive.         No Concomitant medication reported.  It had been reported that Symptoms included fever, sore throat, a scratchy cough, body aches, hip pain, and back pain. It had been reported that the patient regularly takes blood pressure medication, and after taking her liquid high blood pressure medication her cough improved. She also used a cold cloth on her head for the fever.  It had been reported that they started feeling better around the 24th or 25th of June and tested negative for COVID-19 at that time. Blood pressure medication and Cold cloth was mentioned as treatment medication  Company comment: This spontaneous case concerns a 62 year old female, with concurrent hypertension, who experienced the unexpected non-serious adverse event of special interest COVID-19, which occurred approximately 7 months after receiving the third dose of mRNA1273. Patient tested positive for SARS-COV2-Test on 18-Jun-2022. It was reported that she experienced fever, sore throat, a scratchy cough, body aches, hip pain, and back pain. It had been reported that the patient regularly takes blood pressure medication, and after taking her liquid high blood pressure medication her cough improved. She also used a cold cloth on her head for the fever. Patient started feeling better and tested negative for SARS-COV2-test approximately 7 days after the initial positive result (unspecified test date).  Further details regarding the clinical course and treatment were not provided. The patient's age and concurrent hypertension may be considered as risk factors for COVID-19.  The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2022-600549, US-MODERNATX, INC.-MOD-2022-600610 (E2B Linked Report).; Sender's Comments: This spontaneous case concerns a 62 year old female, with concurrent hypertension, who experienced the unexpected non-serious adverse event of special interest COVID-19, which occurred approximately 7 months after receiving the third dose of mRNA1273. Patient tested positive for SARS-COV2-Test on 18-Jun-2022. It was reported that she experienced fever, sore throat, a scratchy cough, body aches, hip pain, and back pain. It had been reported that the patient regularly takes blood pressure medication, and after taking her liquid high blood pressure medication her cough improved. She also used a cold cloth on her head for the fever. Patient started feeling better and tested negative for SARS-COV2-test approximately 7 days after the initial positive result (unspecified test date).  Further details regarding the clinical course and treatment were not provided. The patient's age and concurrent hypertension may be considered as risk factors for COVID-19.  The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. US-MODERNATX, INC.-MOD-2022-600549:MOD22-017743 US-MODERNATX, INC.-MOD-2022-600610:MOD22-017744